This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cereplast Announces 2012 Second Quarter Financial Results

EL SEGUNDO, Calif., Aug. 14, 2012 (GLOBE NEWSWIRE) -- Cereplast, Inc. (Nasdaq:CERP), a leading manufacturer of proprietary biobased, sustainable bioplastics, today announced its financial results for the second quarter ending June 30, 2012.

"Bringing liquidity into our company and controlling our costs has remained the focus of the entire management team," stated Cereplast Chairman and Chief Executive Officer, Mr. Frederic Scheer. "We continue to make progress with our partner in India to distribute the Cereplast Hybrid Resins® products. We remain excited about this relationship, as we believe it will resolve our receivables issue in the near term while opening the door to multiple revenue generating opportunities. I recently visited Hyderabad with key members from Cereplast's senior management team; we met with our partners in India to review the strategy and progress to date. Based on the trials that have been completed, several parties have been identified that are interested in purchasing up to 2000 tons per month depending on the application."

Mr. Scheer continued, "Although the financial constraints forced us to conserve our working capital, we have maintained our existing research and development capability, and as a result we have been awarded patent protection for high heat resistant polymer composition formulations having polylactic acid. This further improvement of our already valuable intellectual property portfolio, coupled with new distribution agreements with Albis to distribute bioplastic resins in the United Kingdom and Ireland, enables us to maintain our optimism for the future of Cereplast."

Second Quarter 2012 and Recent Highlights:

  • The United States Patent and Trademark Office (USPTO) granted Cereplast patent protection for high heat resistant polymer compositions having polylactic acid (PLA). PLA has limitations in terms of melt strength and heat resistance, which has restricted its use for high temperature applications. In contrast, Cereplast's high heat PLA compositions can be industrially compostable and can retain their structural properties at temperatures greater than 165 degrees Fahrenheit (74 degrees Celsius).
  • Entered into a distribution agreement with Hamburg, Germany-based ALBIS PLASTIC GMBH to supply Cereplast bioplastic resins to the United Kingdom and Ireland. Cereplast has shipped the first purchase order to ALBIS PLASTIC, who will distribute both Cereplast Compostables ® resins, with an emphasis on blown film grades and blow molding grades, as well as Cereplast Sustainables ® resins, including the Cereplast Hybrid Resins ® product line. This contract signifies the growing demand in Europe for bioplastic resins, and expands Cereplast's foothold on the continent.

2012 Second Quarter and First Six Months Financial Results:

Net sales for the three months ended June 30, 2012 were approximately $190,000, compared to $7.6 million for the same period in 2011. Net sales for the first six months of 2012 totaled $293,000 as compared to $14.9 million for the first six months of 2011. The decrease in sales over the prior year was due to our planned transition of all our sales and marketing resources, as well as senior management's efforts toward recovery of past due accounts receivables from our customers and minimizing any additional exposure to our accounts receivable credit risk. Our current period sales were primarily to our established existing U.S. customers with low risk credit limits and prepaid shipments of sample material.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs